Abstract
The clinical syndrome of heart failure is the final pathway for a myriad of diseases that affect the heart, and is a leading and growing cause of morbidity and mortality worldwide. Evidence-based guidelines have provided clinicians with valuable data for better applying diagnostic and therapeutic tools, particularly the overwhelming new imaging technology and other, often expensive, therapies and devices, in heart failure patients. In the Middle East, progress has recently been made with the development of regional and multi-centre registries to evaluate the quality of care for patients with heart failure. A new heart function clinic recently began operation and has clearly resulted in a reduced readmission rate for heart failure patients. Many Middle Eastern countries have observed increases in the prevalence of the risk factors for the development of heart failure, including diabetes mellitus, obesity, and hypertension, with heart failure in the Middle Eastern population developing earlier than it is in their Western counterparts by at least 10 years. The earlier onset of disease is the result of the earlier onset of coronary artery disease, highlighting the need for Middle Eastern countries to establish prevention programs across all age groups. The health systems across the Middle East need to be modified in order to provide improved evidence-based medical care. Existing registries also need to be expanded to include long-term survey data, and additional funding for heart failure research is warranted.
Keywords: Heart failure, risk factors, Middle East, review.
Current Cardiology Reviews
Title:Heart Failure in the Middle East
Volume: 9 Issue: 2
Author(s): Mostafa Q. Al-Shamiri
Affiliation:
Keywords: Heart failure, risk factors, Middle East, review.
Abstract: The clinical syndrome of heart failure is the final pathway for a myriad of diseases that affect the heart, and is a leading and growing cause of morbidity and mortality worldwide. Evidence-based guidelines have provided clinicians with valuable data for better applying diagnostic and therapeutic tools, particularly the overwhelming new imaging technology and other, often expensive, therapies and devices, in heart failure patients. In the Middle East, progress has recently been made with the development of regional and multi-centre registries to evaluate the quality of care for patients with heart failure. A new heart function clinic recently began operation and has clearly resulted in a reduced readmission rate for heart failure patients. Many Middle Eastern countries have observed increases in the prevalence of the risk factors for the development of heart failure, including diabetes mellitus, obesity, and hypertension, with heart failure in the Middle Eastern population developing earlier than it is in their Western counterparts by at least 10 years. The earlier onset of disease is the result of the earlier onset of coronary artery disease, highlighting the need for Middle Eastern countries to establish prevention programs across all age groups. The health systems across the Middle East need to be modified in order to provide improved evidence-based medical care. Existing registries also need to be expanded to include long-term survey data, and additional funding for heart failure research is warranted.
Export Options
About this article
Cite this article as:
Al-Shamiri Mostafa Q., Heart Failure in the Middle East, Current Cardiology Reviews 2013; 9 (2) . https://dx.doi.org/10.2174/1573403X11309020009
DOI https://dx.doi.org/10.2174/1573403X11309020009 |
Print ISSN 1573-403X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6557 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Intravenous Immunoglobulin Therapy in Dermatologic Disorders
Inflammation & Allergy - Drug Targets (Discontinued) Endogenous Retroelements in Cellular Senescence and Related Pathogenic Processes: Promising Drug Targets in Age-Related Diseases
Current Drug Targets MicroRNAs in Genetic Disease: Rethinking the Dosage
Current Gene Therapy Potential Uses of MicroRNA in Lung Cancer Diagnosis, Prognosis, and Therapy
Current Cancer Drug Targets Role of Cardiolipin in Mitochondrial Diseases and Apoptosis
Current Medicinal Chemistry Pancreatic Cancer: Promises and Failures of Target Therapies
Reviews on Recent Clinical Trials Incremental Value of Two Dimensional Speckle Tracking Echocardiography in the Functional Assessment and Characterization of Subclinical Left Ventricular Dysfunction
Current Cardiology Reviews Regenerative Therapies for Improving Myocardial Perfusion in Patients with Cardiovascular Disease: Failure to Meet Expectations but Optimism for the Future
Current Vascular Pharmacology Current Options and Perspectives in the Treatment of Diabetic Neuropathy
Current Pharmaceutical Design Modifiable Risk Factors for Premature Atherosclerosis in Systemic Lupus Erythematosus
Vascular Disease Prevention (Discontinued) Alzheimers Disease: From Pathogenesis to Disease-Modifying Approaches
CNS & Neurological Disorders - Drug Targets Application of Pharmacogenomic Approaches in the Study of Drug Response in Complex Diseases
Current Pharmacogenomics The Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development
Current Drug Metabolism Protective Effect of Notoginsenoside R1 on an APP/PS1 Mouse Model of Alzheimer's Disease by Up-Regulating Insulin Degrading Enzyme and Inhibiting Aβ Accumulation
CNS & Neurological Disorders - Drug Targets Antibiotic Susceptibility and Treatment of Brucellosis
Recent Patents on Anti-Infective Drug Discovery Loop Diuretics Strategies in Acute Heart Failure: From Clinical Trials to Practical Application
Current Drug Targets Therapeutic Applications of Human Heme Oxygenase Gene Transfer and Gene Therapy
Current Pharmaceutical Design Vasoprotective Actions of the Atrial Natriuretic Peptide
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Gene Therapy for Ischemic Brain Diseases
Current Gene Therapy Meet Our Editorial Board Member
Current Cardiology Reviews